0 items USD 0.00Search
Your search for "globaldata lysosomal storage disorder global clinical trials review h2 2015" gave back 84108 results.
Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
AAV is transformed from a naturally occurring virus into a delivery mechanism for gene therapy. The viral DNA is replaced with new DNA, and it...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Neurology Clinical Trial market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
April 2023
Price: USD 4,480.00
Clinical Trial Material means any raw materials, parts, or supplies used in the ordinary course of development of a Product for which regulatory...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Neurometabolic disorders are genetic disorders that disrupt how the body uses or produces energy from food. When this happens, there may be too much...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Lysosomal Acid Lipase Deficiency (LALD) Treatment market was valued at US$ 476.5 million in 2023 and is anticipated to reach US$ 860.9...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Highlights The global Lysosomal Acid Lipase Deficiency (LALD) Treatment market was valued at US$ 523.1 million in 2022 and is anticipated to reach US...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook Summary GBI Research’s latest report, "Gene Therapies: A...
Catalog:
CBR Pharma Insights
September 2015
Price: USD 2,995.00
Highlights The global Lysosomal Alpha Glucosidase market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Lysosomal Alpha Glucosidase market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Market Analysis and Insights: Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market The global Lysosomal Acid Lipase Deficiency (LALD)...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
